Active Pine plans to divest up to one percent equity in Biocon, selling 1.66 crore shares worth Rs 638 crore through a block deal at Rs 385 per share. This financial move coincides with Biocon launching a ten-year partnership in Brazil for the commercialization of Pertuzumab, strengthening the biotechnology firm's international footprint and expanding its global oncology portfolio significantly.
Active Pine to Sell Biocon Stake Worth Rs 638 Crore
Active Pine plans to divest up to one percent equity in Biocon, selling 1.66 crore shares worth Rs 638 crore through a b...
By Dhallo News · September 8, 2026 at 7:49 PM IST
Source: Economic Times - NRI
SOURCE: Economic Times - NRI
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion